Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

cardinal health - naloxone hydrochloride (unii: f850569pqr) (naloxone - unii:36b82amq7n) - naloxone hydrochloride 1 mg in 1 ml - naloxone hydrochloride injection is indicated for the complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics, propoxyphene, methadone and certain narcotic-antagonist analgesics: nalbuphine, pentazocine and butorphanol. naloxone hydrochloride is also indicated for the diagnosis of suspected acute opioid overdosage. naloxone hydrochloride injection may be useful as an adjunctive agent to increase blood pressure in the management of septic shock. naloxone hydrochloride injection is contraindicated in patients known to be hypersensitive to it.

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

general injectables & vaccines, inc. - naloxone hydrochloride (unii: f850569pqr) (naloxone - unii:36b82amq7n) - naloxone hydrochloride 1 mg in 1 ml - naloxone hydrochloride injection is indicated for the complete or partial reversal of narcotic depression, including respiratory depression, induced by opioids including natural and synthetic narcotics, propoxyphene, methadone and certain narcotic-antagonist analgesics: nalbuphine, pentazocine and butorphanol. naloxone hydrochloride is also indicated for the diagnosis of suspected acute opioid overdosage. naloxone hydrochloride injection may be useful as an adjunctive agent to increase blood pressure in the management of septic shock. naloxone hydrochloride injection is contraindicated in patients known to be hypersensitive to it.

Iisrael - inglise - Ministry of Health

rafa laboratories ltd - naloxone hydrochloride (as dihydrate); oxycodone hydrochloride - tablets prolonged release - naloxone hydrochloride (as dihydrate) 15 mg; oxycodone hydrochloride 30 mg - oxycodone and naloxone - targin is indicated for the relief of moderate to severe pain.the oxycodone component is indicated for the relief of moderate to severe pain in adults who require continuous around the- clock opioid analgesia for several days or more. the opioid antagonist naloxone is added to counteract opioid-induced constipation by blocking the action of oxycodone at opioid receptors locally in the gut.

Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

indivior pty ltd - buprenorphine hydrochloride, quantity: 2.16 mg (equivalent: buprenorphine, qty 2 mg); naloxone hydrochloride dihydrate, quantity: 0.61 mg (equivalent: naloxone, qty 0.5 mg) - soluble film - excipient ingredients: sunset yellow fcf; polyethylene oxide; hypromellose; maltitol; citric acid; acesulfame potassium; sodium citrate; titanium dioxide; propylene glycol; purified water; industrial methylated spirit; flavour - for the treatment of opiate dependence within a framework of medical, social, and psychological treatment.

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

generics (uk) limited - naloxone hydrochloride dihydrate; oxycodone hydrochloride - prolonged-release tablet - 5 / 2.5 milligram(s) - natural opium alkaloids; oxycodone, combinations

Iirimaa - inglise - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - naloxone hydrochloride dihydrate; oxycodone hydrochloride - prolonged-release tablet - 5 mg/ 2.5 milligram(s) - natural opium alkaloids; oxycodone, combinations

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - naloxone hydrochloride dihydrate 5.45mg equivalent to naloxone hydrochloride anhydrous 5 mg; oxycodone hydrochloride 10mg;   - modified release tablet - 10/5mg - active: naloxone hydrochloride dihydrate 5.45mg equivalent to naloxone hydrochloride anhydrous 5 mg oxycodone hydrochloride 10mg   excipient: ethylcellulose lactose monohydrate magnesium stearate opadry white 85f18422 povidone purified talc   stearyl alcohol - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia. the naloxone component in a fixed combination with oxycodone is indicated for the therapy and/or prophylaxis of opioid-induced constipation.

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - naloxone hydrochloride dihydrate 10.9mg equivalent to naloxone hydrochloride anhydrous 10 mg; oxycodone hydrochloride 20mg;   - modified release tablet - 20/10mg - active: naloxone hydrochloride dihydrate 10.9mg equivalent to naloxone hydrochloride anhydrous 10 mg oxycodone hydrochloride 20mg   excipient: ethylcellulose lactose monohydrate magnesium stearate opadry pink 85f24151 povidone purified talc   stearyl alcohol - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia. the naloxone component in a fixed combination with oxycodone is indicated for the therapy and/or prophylaxis of opioid-induced constipation.

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - naloxone hydrochloride dihydrate 21.8mg equivalent to naloxone hydrochloride anhydrous 20 mg; oxycodone hydrochloride 40mg;   - modified release tablet - 40/20mg - active: naloxone hydrochloride dihydrate 21.8mg equivalent to naloxone hydrochloride anhydrous 20 mg oxycodone hydrochloride 40mg   excipient: ethylcellulose lactose monohydrate magnesium stearate opadry yellow 85f32109 povidone purified talc   stearyl alcohol - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia. the naloxone component in a fixed combination with oxycodone is indicated for the therapy and/or prophylaxis of opioid-induced constipation.

Uus-Meremaa - inglise - Medsafe (Medicines Safety Authority)

mundipharma new zealand ltd - naloxone hydrochloride dihydrate 2.73mg equivalent to naloxone hydrochloride anhydrous 2.5 mg; oxycodone hydrochloride 5mg;   - modified release tablet - 5/2.5mg - active: naloxone hydrochloride dihydrate 2.73mg equivalent to naloxone hydrochloride anhydrous 2.5 mg oxycodone hydrochloride 5mg   excipient: ethylcellulose hyprolose lactose monohydrate magnesium stearate opadry blue 85f30569 purified talc   stearyl alcohol - the management of moderate to severe chronic pain unresponsive to non-narcotic analgesia. the naloxone component in a fixed combination with oxycodone is indicated for the therapy and/or prophylaxis of opioid-induced constipation.